MIT chemists synthesize plant-derived molecules that hold potential as pharmaceuticals
Large multi-ring-containing molecules known as oligocyclotryptamines have never been produced in the lab until now.
MIT-Takeda Program wraps up with 16 publications, a patent, and nearly two dozen projects completed
The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.
A smarter way to streamline drug discovery
The SPARROW algorithm automatically identifies the best molecules to test as potential new medicines, given the vast number of factors affecting each choice.
Symposium highlights scale of mental health crisis and novel methods of diagnosis and treatment
Co-hosted by the McGovern Institute, MIT Open Learning, and others, the symposium stressed emerging technologies in advancing understanding of mental health and neurological conditions.
MIT Faculty Founder Initiative announces three winners of entrepreneurship awards
Twelve finalists participated in initiative and 2023-24 MIT-Royalty Pharma Prize Competition, designed to support female biotech pioneers.
Study models how ketamine’s molecular action leads to its effects on the brain
New research addresses a gap in understanding how ketamine’s impact on individual neurons leads to pervasive and profound changes in brain network function.
A noninvasive treatment for “chemo brain”
Stimulating gamma brain waves may protect cancer patients from memory impairment and other cognitive effects of chemotherapy.
A new way to deliver drugs more efficiently
Core-shell structures made of hydrogel could enable more efficient uptake in the body.
2023-24 Takeda Fellows: Advancing research at the intersection of AI and health
Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.
Angela Koehler appointed faculty director of the Deshpande Center
A biotech entrepreneur, Koehler will help faculty and students launch startups and bring new products to market through the MIT Deshpande Center for Technological Innovation.
MIT researchers to lead a new center for continuous mRNA manufacturing
A pilot-scale system, enabled by an $82 million award from the FDA, aims to accelerate the development and production of mRNA technologies.
Generative AI imagines new protein structures
“FrameDiff” is a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.
Novo Nordisk to support MIT postdocs working at the intersection of AI and life sciences
MIT-Novo Nordisk Artificial Intelligence Postdoctoral Fellows Program will support up to 10 postdocs annually over five years.
From molecular to whole-brain scale in a simple animal, study reveals serotonin’s effects
With full genetic control and visibility into neural activity and behavior, MIT scientists map out chemical’s role in behavior.
Researchers develop novel AI-based estimator for manufacturing medicine
A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.